These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 28217372)

  • 1. Psychotropic drugs and liver disease: A critical review of pharmacokinetics and liver toxicity.
    Telles-Correia D; Barbosa A; Cortez-Pinto H; Campos C; Rocha NB; Machado S
    World J Gastrointest Pharmacol Ther; 2017 Feb; 8(1):26-38. PubMed ID: 28217372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic changes of psychotropic drugs in patients with liver disease: implications for dose adaptation.
    Schlatter C; Egger SS; Tchambaz L; Krähenbühl S
    Drug Saf; 2009; 32(7):561-78. PubMed ID: 19530743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatic tolerance of atypical antipsychotic drugs].
    Dumortier G; Cabaret W; Stamatiadis L; Saba G; Benadhira R; Rocamora JF; Aubriot-Delmas B; Glikman J; Januel D
    Encephale; 2002; 28(6 Pt 1):542-51. PubMed ID: 12506267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Insight Concerning Therapeutic Drug Monitoring-The Importance of the Concept of Psychonephrology.
    Hashimoto M; Maeda H; Oniki K; Yasui-Furukori N; Watanabe H; Saruwatari J; Kadowaki D
    Biol Pharm Bull; 2022; 45(7):834-842. PubMed ID: 35786590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychotropic medications and cytochrome P450 2D6: pharmacokinetic considerations in the elderly.
    Shulman RW; Ozdemir V
    Can J Psychiatry; 1997 Jun; 42 Suppl 1():4S-9S. PubMed ID: 9220124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication.
    Yonkers KA; Kando JC; Cole JO; Blumenthal S
    Am J Psychiatry; 1992 May; 149(5):587-95. PubMed ID: 1575248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatotoxicity of commonly used drugs: nonsteroidal anti-inflammatory drugs, antihypertensives, antidiabetic agents, anticonvulsants, lipid-lowering agents, psychotropic drugs.
    Chitturi S; George J
    Semin Liver Dis; 2002; 22(2):169-83. PubMed ID: 12016548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug administration in chronic liver disease.
    Westphal JF; Brogard JM
    Drug Saf; 1997 Jul; 17(1):47-73. PubMed ID: 9258630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychotropic drugs and renal failure: translating the evidence for clinical practice.
    Baghdady NT; Banik S; Swartz SA; McIntyre RS
    Adv Ther; 2009 Apr; 26(4):404-24. PubMed ID: 19444657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lopinavir/ritonavir: a review of its use in the management of HIV infection.
    Cvetkovic RS; Goa KL
    Drugs; 2003; 63(8):769-802. PubMed ID: 12662125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Informations on psychotropics and their adaptations for patients suffering from mental disorders in France during the SARS-CoV-2 epidemic].
    Javelot H; Llorca PM; Drapier D; Fakra E; Hingray C; Meyer G; Dizet S; Egron A; Straczek C; Roser M; Masson M; Gaillard R; Fossati P; Haffen E
    Encephale; 2020 Jun; 46(3S):S14-S34. PubMed ID: 32376004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analgesics in patients with hepatic impairment: pharmacology and clinical implications.
    Bosilkovska M; Walder B; Besson M; Daali Y; Desmeules J
    Drugs; 2012 Aug; 72(12):1645-69. PubMed ID: 22867045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of psychotropic drugs in special populations.
    Rudorfer MV
    J Clin Psychiatry; 1993 Sep; 54 Suppl():50-4; discussion 55-6. PubMed ID: 8407858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychopharmacology in patients with hepatic and gastrointestinal disease.
    Leipzig RM
    Int J Psychiatry Med; 1990; 20(2):109-39. PubMed ID: 2203695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic disease and drug pharmacokinetics.
    Williams RL; Mamelok RD
    Clin Pharmacokinet; 1980; 5(6):528-47. PubMed ID: 7002418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on psychotropic medication use in renal disease.
    Cohen LM; Tessier EG; Germain MJ; Levy NB
    Psychosomatics; 2004; 45(1):34-48. PubMed ID: 14709759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanisms of interactions of psychotropic drugs with liver and brain cytochrome P450 and their significance for drug effect and drug-drug interactions.
    Daniel WA; Bromek E; Danek PJ; Haduch A
    Biochem Pharmacol; 2022 May; 199():115006. PubMed ID: 35314167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Liver disease induced by psychiatric drugs].
    Lamela CA
    Vertex; 2005; 16(59):29-34. PubMed ID: 15785786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of antidepressants in patients with hepatic impairment.
    Mauri MC; Fiorentini A; Paletta S; Altamura AC
    Clin Pharmacokinet; 2014 Dec; 53(12):1069-81. PubMed ID: 25248846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of chronic renal failure on the disposition of highly hepatically metabolized drugs.
    Yuan R; Venitz J
    Int J Clin Pharmacol Ther; 2000 May; 38(5):245-53. PubMed ID: 10839468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.